Previous Close | 30.70 |
Open | 32.04 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's Range | 31.42 - 32.08 |
52 Week Range | 25.64 - 43.40 |
Volume | |
Avg. Volume | 45,694 |
Market Cap | 4.732B |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | 31.42 |
EPS (TTM) | 1.00 |
Earnings Date | Dec 12, 2024 |
Forward Dividend & Yield | 0.15 (0.48%) |
Ex-Dividend Date | Mar 15, 2024 |
1y Target Est | 35.00 |
With its stock down 11% over the past three months, it is easy to disregard SCHOTT Pharma KGaA (ETR:1SXP). However...
Schott Pharma AG & CO KGaA (WBO:1SXP) reports a 21% revenue increase and raises its full-year growth guidance, while addressing challenges in production and currency impacts.